Welcome to the Podiatry Homepage
The Colorado Podiatry Board was instituted as part of the Podiatrists Practice Act in order to regulate the practice of podiatry in Colorado. The Board ensures that licensed professionals are acting in accordance with the standards of care as outlined in the Podiatrists Practice Act. Licensure is mandatory to practice podiatric medicine or perform podiatric surgery in Colorado or to treat Colorado patients.
The Podiatry Board is a Type I Board, meaning that it is policy autonomous and made up of professional and public members (four podiatrists and one public member). The decisions made by the Podiatry Board are not subject to administrative review. The Podiatry Board does not have the authority to arbitrate or adjudicate fee disputes.
- Program/Board Members
Karen Phelan, Program Director
Colorado Podiatry Board
1560 Broadway, Suite 1350
Denver, CO 80202
Kristine Hoffman, DPM, President
Professional Member | Term Expires: March 17, 2023
Brett D. Sachs, DPM, Vice President
Professional Member | Term Expires: March 17, 2025
Michael Vaardahl, DPM
Professional Member | Term Expires: March 17, 2024
Staci Bogin, DPM
Professional Member | Term Expires: March 17, 2024
Public Member | Term Expires: March 17, 2026
- Public Notices
Joint Stakeholder Meeting - August 29, 2022
The Division of Profession and Occupations held a Joint Stakeholder Meeting for all Healthcare Boards with Prescriptive Authority to allow stakeholders an opportunity to provide feedback on the implementation of Colorado House Bill 22-1115 (Concerning the Prescription Drug Monitoring Program, and, in connection therewith, making an appropriation).
Joint Stakeholder Meeting - August 12, 2022
The Division of Professions and Occupations' held a Joint Stakeholder Meeting for all Healthcare Boards and Programs that allowed stakeholders an opportunity to provide feedback, and help develop new and/or revised rules to implement Colorado House Bill 22-1284 (Concerning updates to state surprise billing laws to facilitate the implementation of surprise billing protections, and, in connection therewith, aligning state law with the federal "No Surprises Act").
Joint Stakeholder Meeting - July 29, 2022
The Division of Professions and Occupations' held a Joint Stakeholder Meeting for all Boards and Programs that allowed stakeholders an opportunity to provide feedback, and help develop new rules to implement the directives of Executive Order D-2022-034 (Protecting Colorado’s Workforce and Expanding Licensing Opportunities).
Joint Stakeholder Meeting - July 22, 2022
The Division of Professions and Occupations' held a Joint Stakeholder Meeting for all healthcare Boards and Programs that allowed stakeholders an opportunity to provide feedback, and help develop new rules to implement the directives of Executive Order D-2022-032 (Directing State Agencies to Protect Access to Reproductive Health Care in Colorado).
Stakeholder Meeting - August 1, 2022
The Colorado Podiatry Board held a Stakeholder Meeting that allowed stakeholders an opportunity to provide feedback on the proposed changes to Rule 1.6, to implement Colorado Senate Bill 22-116 (Concerning the ability of an individual to obtain an occupational credential through the occupational credential portability program); and identify what changes should be considered to Rule 1.11 (Supervision of and Practice by Physician Assistants).
- Notice, Draft Rule 1.6, Current Rule 1.11, and SB22-116
- Stakeholder Meeting: August 1, 2022
- Joint SB22-116 Stakeholder Meeting: June 10, 2022
Permanent Rulemaking Hearing - June 3, 2022
The Colorado Podiatry Board will hold a Permanent Rulemaking Hearing to allow stakeholders a final opportunity to provide testimony before the Board considers adopting the proposed changes throughout the Board’s rules pursuant to the rule review mandated by section 24-4-103.3, C.R.S. The purpose of the rule review is to assess the continuing need, appropriateness, and cost-effectiveness of the rules to determine if they should be continued in their current form, modified, or repealed. Some of the major proposed changes include the consolidation of all Board rules into one document, and a complete re-organization of the rules.
- Friday, June 3, 2022, at 9:00 A.M. (MDT)
- Webinar Link
- Sign up to Testify
- Notice, Draft Rules, and Written Comments
- Stakeholder Meeting: February 18, 2022
Joint Stakeholder Meeting - October 15, 2021
The State Board of Pharmacy, State Board of Nursing, Colorado Medical Board, Colorado Dental Board, Colorado Podiatry Board, State Board of Veterinary Medicine, and State Board of Optometry held a Joint Stakeholder Meeting to gather feedback to identify and create a list of prescription drugs and substances (using evidence-based practices), in addition to controlled substances, that have a substantial potential for abuse and must require pharmacists and prescription drug outlets to report those prescription drugs and substances to the Prescription Drug Monitoring Program (PDMP) when dispensed to a patient. The Board is considering the development of new rules to monitor non-controlled prescription drugs/substances, as allowed per section 12-280-404(2)(b)(I), C.R.S., of Colorado Senate Bill 21-098.
Permanent Rulemaking Hearing - September 10, 2021
The Colorado Podiatry Board held a Permanent Rulemaking Hearing on September 10, 2021, that allow stakeholders a final opportunity to provide feedback before the Board considered adopting Rule 330 (3 CCR 712-21), to implement Colorado House Bill 21-1276 (Concerning the prevention of substance use disorders).
- Notice, Draft Rule, and HB21-1276
- Joint HB21-1276 Stakeholder Meeting (recording): July 23, 2021
- Effective Date: October 30, 2021
Permanent Rulemaking Hearing - June 4, 2021
The Colorado Podiatry Board held a Permanent Rulemaking Hearing on June 4, 2021, that allowed stakeholders a final opportunity to provide feedback before the Board considered adopting revisions to Rule 310, to correct language in the rule that conflicted with portions of the statute in section 12-30-115, C.R.S., of Colorado Senate Bill 20-102 (Concerning required disclosures to patients regarding formal actions based on sexual misconduct).
- Notice, Draft Rule, and SB20-102
- Joint Stakeholder Meeting Recording: February 11, 2021
- Effective Date: July 30, 2021
Permanent Rulemaking Hearing - December 4, 2020
The Colorado Podiatry Board held a virtual Permanent Rulemaking Hearing to consider adopting new rules to implement Colorado Senate Bill 19-079 (Requirement of Practitioners to Prescribe Controlled Substances Electronically), and Colorado Senate Bill 20-102 (Concerning the Requirement of Providers to provide Disclosure of Sexual Misconduct to Patients prior to Treatment).
- Legislative Updates
- 2022 New Legislation
- HB22-1041: Privacy Protections For Protected Persons
- HB22-1098: Department Of Regulatory Agencies Barriers To Practice Regulated Professions
- HB22-1165 Rule Review Bill
- HB22-1240 Mandatory Reporters
- HB22-1267 Culturally Relevant Training Health Professionals
- HB22-1270 Change Term Name-based Criminal History Record Check
- HB22-1278: Behavioral Health Administration
- HB22-1291: Sunrise Review Professions Occupations
- SB22-013: Boards and Commissions
- SB22-027: Prescription Drug Monitoring Program
- SB22-076: Complaint Occupational License Official Acts
- SB22-116: Increase Occupational Credential Portability
- SB22-143: Update Common Provision Term Regulator Title 12
- SB22-162: Administration Organization Act Modernization
- SB22-174: Sunset Review Hearing Criteria
- SB22-226: Programs To Support Health-care Workforce
- 2021 New Legislation
- HB21-1012: Expand Prescription Drug Monitoring Program
- HB 21-1123: CAPS Check for Substantiated Cases of Mistreatment of an At-Risk Adult
- HB21-1169: Prohibit Discrimination Organ Transplant Recipient
- HB21-1198: Healthcare Billing Requirements for Indigent Patients
- HB21-1232: Standardized Health Benefit Plan Colorado Option
- HB21-1276 Prevention of Substance Use Disorders
- HB21-1297: Pharmacy Benefit Manager and Insurer Requirements
- HB21-1300: Health-care Provider Liens for Injured Persons
- SB21-097: Sunset Medical Transparency Act
- SB21-011: Pharmacist Prescribe Dispense Opiate Antagonist
- SB21-077: Remove Lawful Presence Verification Credentialing
- SB21-094: Sunset Continue State Board of Pharmacy
- SB21-098: Sunset Prescription Drug Monitoring Program
- SB21-122: Opiate Antagonist Bulk Purchase And Standing Orders
- SB21-271: Misdemeanor Reform
- 2020 New Legislation
- 2022 New Legislation
- Meeting Minutes